| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_950515235daadf7e44e4e2b3dfb0be19 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-75 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 |
| filingDate |
1994-11-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2008-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f3d2b6998ec6b6a9154f3f54b9e4f475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_63698ed48570a7aa2b1fe8c368829b4a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7525b0a64127fce1215e43cd0514a35d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_465267dae389b350716755c04a054c47 |
| publicationDate |
2008-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-0678524-B1 |
| titleOfInvention |
Anti-human soluble fibrin antibodies, hybridoma producing them, and immunoassaying method |
| abstract |
A monoclonal antibody that reacts with a human soluble fibrin but not with a human fibrinogen; a hybridoma that secretes the above antibody; and a method of assaying a human soluble fibrin with the above antibody. It is possible to determine the content of soluble fibrin in the plasma of a patient specifically, readily and rapidly by agglutination and EIA without being affected by plasma fibrinogen, plasmin hydrolysis product of fibrinogen, fibrin fragment, and plasmin hydrolysis product of stabilized fibrin even without pretreating the plasma sample. <IMAGE> |
| priorityDate |
1993-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |